REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD

Similar documents
Report. Uganda Pharmaceutical Sector Scan JUNE 2010

AGREEMENT ON COMMON PRINCIPLES AND RULES OF CIRCULATION OF MEDICINAL PRODUCTS WITHIN THE EURASIAN ECONOMIC UNION. (Moscow, 23 December 2014)

REPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD DRAFT GUIDELINE FOR IMPORTATION OF ORPHAN MEDICINAL SUBSTANCES IN KENYA

FOOD AND DRUGS AUTHORITY (FDA) GHANA

Ms. Fortunate Fakudze Senior Pharmacist Ministry of Health KINGDOM OF SWAZILAND

14 th International Conference of Drug Regulatory Authorities 30 th November December 2010 Singapore

quality and safety of pharmacy preparations in Europe

RESOLUTION OF THE STATE GREAT KHURAL OF MONGOLIA. 11 October 2002 No: 68 Ulaanbaatar. Adoption of the Government Policy on Drugs

REGULATORY CHALLENGES IN SOUTH AFRICA

WAREHOUSING AND DISTRIBUTION OF CANNABIS PRODUCTS. RACI Pharmaceutical Science Group (NSW) Supply and Use of Medicinal Cannabis

The Role of the Responsible Pharmacist (RP)

LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY

MEDICINES REGULATORY AUTHORITIES: CURRENT STATUS AND THE WAY FORWARD. Report of the Regional Director EXECUTIVE SUMMARY

PROVISIONAL TRANSLATION

Questionnaire for National Competent Authorities on the availability of Internationally Controlled Substances for medical and scientific purposes

Act on Narcotic Drugs and Psychotropic Substances and Precursors thereof

Drug Administration Law of the People's Republic of China Order of the President of the Peoples Republic of China. (No. 45)

REPUBLIC OF KENYA MINISTRY OF HEALTH PHARMACY AND POISONS BOARD. September 2015, Version 1

DECREE. President of Islamic Republic of Afghanistan Regarding the enforcement of Medicine Law

Medicines and Cosmetics Regulation Unvalidated References:

NATIONAL DRUG POLICY OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA

Regulatory Framework for Medical Devices in South Africa. 23 November 2018 Andrea Keyter Deputy Director: Medical Devices

LAW ON PREVENTION AND SUPPRESSION OF THE ABUSE OF NARCOTIC DRUGS

VOCATIONAL EDUCATION AND TRAINING STANDARD FOR A PHARMACIST S ASSISTANT

Guidelines for Product Recall or Withdrawal

ORDER of the Minister of Health No. 269/2017 of 14 March 2017 on mandatory provision of medicinal product adequate and continuous supplies

Medical Devices. SOUTH AFRICA Bowman Gilfillan

Guideline for the Rational Use of Controlled Drugs

CHAPTER I GENERAL PROVISIONS

SOCIALIST REPUBLIC OF VIET NAM Independence Freedom Happiness Ha Noi, day 14 month 06 year THE NATIONAL ASSEMBLY No: 34/2005/QH11

Food Fortification Regulations, 2016 (Gazetted on 24 October, 2016) ARRANGEMENT OF SECTIONS PART I PRELIMINARY

1. Introduction. 2. Role of PSI as Pharmacy Regulator

Results Framework Document(RFD) for the period for Responsibility Centres (RCs) CENTRAL BUREAU OF NARCOTICS

GUIDE FOR THE NEW ELECTRONIC PAYMENT SYSTEM. Version 1.0 Spanish Agency of Medicines and Medical Devices

Republika e Kosovës Republika Kosovo - Republic of Kosovo Kuvendi - Skupština - Assembly

Unofficial translation /Ministry of Social Affairs and Health. No. 548/2008. Government Decree on Narcotics Control

REPUBLIC OF LITHUANIA LAW ON PHARMACY 22 June 2006 No X-709 Vilnius CHAPTER I GENERAL PROVISIONS

Health Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:

Pharmaceutical Sector Scan

Ensuring the gap between science and practice is filled safely - MHRA

Joy Wingfield LL M, MPhil, BPharm, FRPharmS, Dip Ag Vet Pharm, FCPP Honorary Professor of Pharmacy Law and Ethics, University of Nottingham, UK

MEDICINAL PRODUCTS IN HUMAN MEDICINE ACT

MEDICINES CONTROL COUNCIL

MHRA Anti-counterfeiting Strategy and Supply Chain Guidance

STATUTORY INSTRUMENTS. S.I. No. 599 of 2015 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) REGULATIONS 2015

POISONS SCHEDULING. Monique Reyes Senior Pharmaceutical Officer Pharmaceutical Regulatory Unit NSW Ministry of Health

The Danish Medicines Agency s availability strategy

European Medicines Enforcement Network

COUNTY GOVERNMENT OF NYERI

Working at the MHRA A day in the life of a Pharmaceutical Assessor

Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.

On Medicinal Products and Medical Devices

Federation of Saint Kitts and Nevis

National Drug Policy and Authority Act 1993 (Ch 206)

INTERNATIONAL HALAL CONFERENCE PAKISTAN March 2011, Sheraton Hotel, Karachi, Pakistan

Overview of the PAHO strategy and activities to strengthen National Regulatory Authorities in the Americas

Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law

Minister of Social Affairs. Passed No. 73 RTL 2005, 57, 807 Entry into force

Overview of IMB and Integration of Cosmetics

Regulation of Herbal and Traditional Medicines in Germany BfArM in Dialogue - TradReg 2017

COUNTERFEIT DRUGS IN INDIA

PHARMACY AND POISONS BOARD OF HONG KONG

Presentation to Parliamentary Portfolio Committee on Health

MEDICINES PROMOTION AND RATIONAL USE : The Spanish Experience JOSE LUIS DOPICO

Country specific case studies Best practices to combat counterfeit medicines and to protect public health. Luc Besançon FIP Project Coordinator

International Drug Control Conventions. Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol

Cooperation between HALMED and GMP Inspectorate in supervision of manufacturers: Croatia s experience so far

Lao People s Democratic Republic

Review Article ISSN: Vinod M. Sonawane et al. / Journal of Pharmacy Research 2010, 3(12),

Jamaica. Evaluation Report on Drug Control ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM)

Government Gazette REPUBLIC OF SOUTH AFRICA

Tobacco Free Ireland Action Plan

14 th International Conference of Drug Regulatory Authorities : Progress report from the Western Pacific Region

MEDICINES ACT 395/1987. Unofficial translation; Amendments up to 1340/2010 included

National Policy on Traditional / Complementary Medicine, Malaysia Ministry of Health Malaysia August 2002

QUESTIONS AND ANSWERS Access to Drugs in Exceptional Circumstances

Resolution 59/8 Promotion of measures to target new psychoactive substances and amphetamine-type stimulants

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

BILATERAL SCREENING MEETING

Evidence-Based Clinical Practice Guideline. Treatment & Management of Ocular Disease

Precursor Chemicals. Precursor Chemicals. Overview of the EU Control System. Dr Lorraine Nolan IMB. Camden Court Hotel, May 24 th 2010

Risk analysis for veterinary vaccines in Australia

REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition

ADVANCED MANUFACTURING CAREER CLUSTER

DIRECTIVE 2011/62/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

The effects of the State Sanitary Inspectorate activity in the field of new psychoactive substances (NPS)

Gilberto Gerra. Drug Prevention and Health Branch

EMEA PANDEMIC INFLUENZA CRISIS MANAGEMENT PLAN FOR THE EVALUATION AND MAINTENANCE OF PANDEMIC INFLUENZA VACCINES AND ANTIVIRALS

EDICT ON PROMULGATION OF THE TOBACCO LAW TOBACCO LAW

Article 18. 5) Act No. 108/2000, Article 1. 6) Act No. 83/2004, Article 1. 7) Act No. 167/2007, Article 74.

POLICY GUIDELINES TRADITIONAL MEDICINE DEVELOPMENT. Ministry of Health 2005

Essential Medicines. WHO

UNODC/HONLAF/26/CRP.1

COUNTY GOVERNMENT OF NYERI

Trinidad and Tobago ORGANIZATION OF AMERICAN STATES (OAS) MULTILATERAL EVALUATION MECHANISM (MEM) INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION (CICAD)

THE RESPONSIBLE PHARMACIST REGULATIONS

CDER Compliance Update

(Adopted by the Committee of Ministers on 19 January 2011 at the 1103rd meeting of the Ministers Deputies)

MEDICINES AND RELATED PRODUCTS ACT, 2014 ARRANGEMENT OF SECTIONS

STATUTORY INSTRUMENTS. S.I. No. 531 of 2018 HEALTH PRODUCTS REGULATORY AUTHORITY (FEES) (NO. 2) REGULATIONS 2018

Transcription:

REPUBLIC OF KENYA MINISTRY OF MEDICAL SERVICES PHARMACY AND POISONS BOARD Ensuring the provision of quality, safe and efficacious pharmaceutical products and services. FUNCTIONS OF THE BOARD BACKGROUND The was set up as a Regulatory Authority in1957 by an Act of Parliament. It is a body corporate that is semi autonomous from its parent Ministry of Medical services. The Board regulates the Practice of Pharmacy, Manufacture and Trade in drugs and poisons. 1

MISSION STATEMENT The Board aims to implement appropriate regulatory measures to achieve the highest standards of safety, efficacy and quality for all medicines in Kenya. MISSION OF THE BOARD To regulate and control pharmaceutical services/practice in terms of safety, efficacy and quality of medicines. 2

VISION OF THE BOARD To improve and promote appropriate pharmaceutical care in Kenya. PPB ORGANISATION STRUCTURE MINISTRY OF MEDICAL SERVICES BOARD OF DIRECTORS REGISTRAR DEPUTY REGISTRAR BOARD OF MANAGEMENT MEDICINE INFORMATION DRUG REGISTRATION PHARMACOVIGILENCE PHARMACEUTICAL INSPECTORATE LEGAL OFFICE LICENSING DEPARTMENT TRAINING AND ASSESSMENT DEPT GMP INSPECTORATE IMPORT & EXPORT DEPARTMENT National Quality Control Laboratory 3

of the Board To advice the Minister of Health on matters relating to Poisons Act, CAP 244 laws Of Kenya. As stated in the functions of its Departments. DEPARTMENTS RESPECTIVE FUNCTIONS AS FOLLOWS: 4

Pharmaceutical Inspectorate Evaluation for issuance of licenses for Retail, Wholesale premises and pharmaceutical manufacturers. Inspection of Medicine s entry points. Inspection of medicines distribution channels Issuing certificate of destruction for expired, counterfeit and substandard products. Drug Registration Receiving product applications, dossiers and samples for registration. Evaluation of dossiers and samples submitted. Maintenance of products register. 5

Good Manufacturing Practice (GMP) Inspectorate Ensuring of cgmp compliance byall pharmaceutical manufactures (locally and internationally) Regulation of trade of Precursors, narcotics and psychotropic substances. Quarterly and annual returns of Precursors, Narcotics and Psychotropic substances to the International Narcotics and Control Board (INCB) in Vienna. Trade Department Evaluation and Issuance of import and export permits for medicines and Pharmaceutical raw materials. Promote and maintain collaborative linkages with bodies to foster trade in Pharmaceuticals Liaising i i with the Pharmaceutical Industry on trade issues. 6

Training and Assessment Department Regulation of pharmaceutical training i institutions. Evaluation for the Registration of Pharmacist and Pharmaceutical technologist. Issuance of Annual Practice license to Pharmacist and Pharmaceutical Technologist. Issuance of Pharmaceutical Representatives Permits. Medicine Information Evaluation for approval of medicinal i advertisement Serving as medicines and Poisons information centre. Ensuring provision Rational use of Medicines Issuing health alerts and press release for public information. 7

Pharmacovigilance and Post Market Surveillance Unit Collaboration with post-market t surveillance for Adverse Drug Reaction (ADR). Assessment and validation of completed ADR case report forms. Maintaining contact with local/international on Pharmacovigilance. Coordinating clinical trial activities. Legal Office : Handling Legal issues 8

Support Departments Finance Procurement. ICT. 9